Herantis Pharma Oyj: Managers’ Transactions – Tone Kvåle

Herantis Pharma Plc | Company Release | January 26, 2024 at 12:50:00 EET

Herantis Pharma Oyj – Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Tone Kvåle
Position: Chief Financial Officer
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 50731/5/4
____________________________________________

Transaction date: 2024-01-25
Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)
Instrument type: SHARE
ISIN: FI4000087861
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 5000 Unit price: 1.5 EUR

Aggregated transactions (1):
Volume: 5000 Volume weighted average price: 1.5 EUR
____________________________________________

Further information:
Julie Silber/Gabriela Urquilla
Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19
Email: ir@herantis.com

Certified Advisor: UB Securities Ltd, +358 9 25 380 225

Company website: www.herantis.com

Distribution:

Main media
www.herantis.com